Previous 10 | Next 10 |
GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today ...
GUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today ...
GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today a...
China-based biotech Burning Rock Biotech Limited ( NASDAQ: BNR ) added ~9% in the morning hours Tuesday after announcing that the FDA issued its Breakthrough Device Designation for the company’s multi-cancer detection test OverC. The blood-based test is designed for the ear...
IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its OverC™ Multi-Cancer Detection Blood Test (MCDBT) has been grant...
Summary Burning Rock Biotech went public in mid-2020, raising approximately $248 million in gross proceeds in an IPO and private placement. The company provides a variety of cancer screening test capabilities in China. BNR has reduced forward growth guidance, but I fear the sharp ri...
Burning Rock Biotech Limited (BNR) Q3 2022 Earnings Conference Call November 16, 2022 08:30 A.M. ET Company Participants Yusheng Han - Chairman and CEO Dr. Shaokun Chuai - COO Leo Li - CFO Conference Call Participants Alexis Yan - Morgan Stanley M...
The following slide deck was published by Burning Rock Biotech Limited in conjunction with their 2022 Q3 earnings call. For further details see: Burning Rock Biotech Limited 2022 Q3 - Results - Earnings Call Presentation
Burning Rock Biotech press release ( NASDAQ: BNR ): Q3 GAAP EPS of -$0.31 beats by $0.03 . Revenue of $21.74M (+22.1% Y/Y) misses by $0.32M . Non-GAAP gross margin was 75.7% for the three months ended September 30, 2022, compared to 73.4% for the same peri...
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, t...
News, Short Squeeze, Breakout and More Instantly...
Burning Rock Biotech Limited Company Name:
BNR Stock Symbol:
NASDAQ Market:
Burning Rock Biotech Limited Website:
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 35.3% to $0.3248 on volume of 164,333,109 shares SRIVARU Holding Limited (SVMH) rose 62.4% to $0.2581 on volume of 68,213,933 shares NVIDIA Corporation (NVDA) rose 2.9% to $129.43 on volume o...
2024-07-07 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-17 22:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...